Accessibility settings

This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (5923) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (280) Pharmacovigilance (250)

Published on in Vol 24, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35464, first published .
Pharmacist's hand reaching for medication box on shelf in pharmacy

A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation

A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation

Authors of this article:

Suehyun Lee1 Author Orcid Image ;   Jeong Hoon Lee2 Author Orcid Image ;   Grace Juyun Kim2 Author Orcid Image ;   Jong-Yeup Kim3 Author Orcid Image ;   Hyunah Shin3 Author Orcid Image ;   Inseok Ko3 Author Orcid Image ;   Seon Choe2 Author Orcid Image ;   Ju Han Kim2 Author Orcid Image
Article Authors Cited by (4) Tweetations (6) Metrics

Journals

  1. Kim H, Yoon J, Lee K. Investigating the Safety Profile of Fast‐Track COVID‐19 Drugs Using the FDA Adverse Event Reporting System Database: A Comparative Observational Study. Pharmacoepidemiology and Drug Safety 2024;33(11) View
  2. Jeon J, Hong E, Kim J, Lee S, Kim H. Predicting the physiological effects of multiple drugs using electronic health record. Computers in Biology and Medicine 2025;184:109485 View
  3. Xu M, Wang Z, Yu B. Original research a real-world study of adverse events of nafamostat mesylate and sodium citrate based on the world health organization-VigiAccess database. Frontiers in Pharmacology 2026;17 View
  4. Benali A, Boudiaf K, Touati S. Variational Autoencoder for Unsupervised Detection of Adverse Drug Reaction Signals from Electronic Health Record Clinical Notes and Laboratory Abnormalities. Journal of Artificial Intelligence for Healthcare Systems 2024;3(1) View